Safety aspects of GH replacement

Eur J Endocrinol. 2009 Nov:161 Suppl 1:S65-74. doi: 10.1530/EJE-09-0287. Epub 2009 Aug 14.

Abstract

In adults, GH replacement therapy will often be maintained for decades. Owing to the long duration of GH replacement in many adults, it is essential to establish the long-term safety aspects of the treatment. In this review, studies that have investigated the safety profile of long-term GH replacement will be reviewed with an emphasis on studies based on data from the Pfizer International Metabolic Database (KIMS). These studies show that long-term GH replacement in adults is safe and that long-term GH replacement may even improve cardiovascular mortality and morbidity in GH-deficient adults.

Publication types

  • Review

MeSH terms

  • Adult
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control
  • Databases, Factual
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / metabolism
  • Human Growth Hormone / administration & dosage
  • Human Growth Hormone / adverse effects*
  • Human Growth Hormone / deficiency*
  • Humans
  • Hypothalamic Neoplasms / epidemiology
  • Insulin / metabolism
  • International Cooperation
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasms / chemically induced
  • Neoplasms / epidemiology*
  • Pituitary Neoplasms / epidemiology
  • Risk Assessment
  • Risk Factors

Substances

  • Insulin
  • Human Growth Hormone